Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 27, 2026Blood AdvancesOpen Access

Rapid and Reproducible Karyotyping with Long Read Sequencing in AML Patients

View Full Paper
Ask AI
Bookmark
Share

Authors

MHMichael HeuserADAnna DolnikIAIsabell Arnhardt

Discussion

Loading...

Member takes

Overview

Randomized trial demonstrates rapid detection of chromosomal abnormalities in AML, suggesting improved treatment timelines.

Key Points

  • The aim is to evaluate a long-read sequencing approach for rapid karyotyping in acute myeloid leukemia patients.
  • Analyzed 100 diagnostic AML samples, including both retrospectively and prospectively enrolled cases.
  • Used long-read sequencing low-coverage whole genome sequencing with Oxford Nanopore Technology.
  • Validated reproducibility through replicate sequencing at independent laboratories.
  • LcWGS identified chromosomal aberrations with 93% sensitivity and specificity.
  • Median turnaround time for results was approximately 34 hours, with actionable results in under 72 hours.
  • Patients with complex karyotypes showed significantly shorter overall and relapse-free survival.

Cite This Study

Heuser et al. (2026) studied this question.

synapsesocial.com/papers/6a3f694caea7db3c19540273https://doi.org/10.1182/bloodadvances.2026019960
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Comprehensive and rapid detection of genomic alterations in pediatric leukemias using whole-genome sequencing with adaptive sampling2025 · 1 citations
  2. 2ALTseqTM, a rapid (< 48 hours) whole genome sequencing clinical test for Acute Myeloid Leukemia (AML)2025
  3. 3Sparse whole genome sequencing and machine learning of AML genomes reveals novel, clinically relevant genetics.2025 · 1 citations
  4. 4Rapid diagnosis of acute leukemia with integrated epigenetic and genetic profiling2025 · 2 citations
  5. 5Feasibility and utility of unmatched whole-genome sequencing (uWGS)  for pediatric acute leukemias: An analysis of leukemia precision-based therapy (LEAP) study samples2025